Supplementary Figure 2 from Adjuvant therapy with oncolytic adenovirus Delta-24-RGDOX after intratumoral adoptive T-cell therapy promotes antigen spread to sustain systemic antitumor immunity

Expression of TCRs in CD8+ T cells from pmel-1 (A, gp100-Tet+) or OT-I (B, OVA-Tet+) transgenic mice. Splenocytes from the mice were stained with tetramers binding with TCR specific for gp100 (pmel-1) or OVA (OT-I), and antibody against CD8. Stained cells were analyzed with flow cytometry. The numbers in upright corner of the dot plots indicate the frequency (% of splenocytes) of gp100-targeting (A) or OVA-targeting (B) in CD8+ T cells.